A phase I clinical trial to evaluate the safety and immunogenicity of a booster dose of a recombinant multiclade HIV-1 adenoviral vector vaccine, VRC-HIVADV014-00-VP, in uninfected subjects who were previously immunized with VRC-HIVDNA009-00-VP in VRC 004
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs VRC-HIVADV014-00-VP (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 22 Oct 2007 Status changed from in progress to completed.
- 01 Nov 2005 New trial record.